This announcement is a separate document:
東陽光藥：二零二二年度董事會報告 二零二二年度監事會報告 二零二二年度綜合財務報表 二零二二年年度報告 續聘本公司核數師 重續發行股份及購回H股股份一般性授權 股東週年大會通告 及 二零二三年第一次H股股東類別會議通告
HEC PHARM: 2022 Report of the Board of Directors 2022 Report of the Board of Supervisors 2022 Consolidated Financial Statements 2022 Annual Report Re-appointment of the Auditor of the Company Renewal of the General Mandate to Issue Shares and Repurchase H
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.